PATENT CLAIM ANALYSIS

Application Number: 16130076
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["546", "208000"]

Abstract:
This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , and R 8  are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

Claim (Index 39):
A method for producing bronchodilation in a human patient, the method comprising administering to the patient by inhalation a pharmaceutical composition comprising a pharmaceutically acceptable carrier and biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester or a pharmaceutically acceptable salt thereof; wherein the pharmaceutical composition is administered to the patient in an amount sufficient to provide about 10 \u03bcg/day to about 200 \u03bcg/day of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]-methylamino}ethyl)piperidin-4-yl ester or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.75
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15876525', '14539550', '13438105', '11880007', '11077433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8370457529374273
- 35 USC 102 Novelty (BERT): 0.6197550703610033
- Combined Prediction Score: 0.8153166846797849
- Mean Citation Score: 499.513046
- Max Citation Score: 543.49255
- Similarity Product: 517.1489691515535

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test